Cardiol Therapeutics (CRDL) News Today C$3.13 +0.03 (+0.97%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 23 at 5:16 PM | marketbeat.comCardiol Therapeutics (TSE:CRDL) Stock Price Up 1.6%Cardiol Therapeutics (TSE:CRDL) Trading Up 1.6%July 16, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Trading Down 0.7%Cardiol Therapeutics (TSE:CRDL) Shares Down 0.7%June 25, 2024 | insidertrades.comDavid Elsley Acquires 50,000 Shares of Cardiol Therapeutics Inc. (TSE:CRDL) StockJune 24, 2024 | marketbeat.comInsider Buying: Cardiol Therapeutics Inc. (TSE:CRDL) Director Purchases 50,000 Shares of StockCardiol Therapeutics Inc. (TSE:CRDL - Get Free Report) Director David Elsley bought 50,000 shares of the business's stock in a transaction that occurred on Monday, June 24th. The shares were bought at an average cost of C$2.77 per share, for a total transaction of C$138,490.00.June 10, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Shares Up 11.7%Cardiol Therapeutics (TSE:CRDL) Trading 11.7% HigherMay 14, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Cardiol Therapeutics (CRDL) and MicroPort Scientific (OtherMCRPF)May 10, 2024 | baystreet.caManufacturing, Housing Due Next Week in CanadaApril 30, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Trading 12.9% Higher Cardiol Therapeutics (TSE:CRDL) Stock Price Up 12.9%April 23, 2024 | markets.businessinsider.comBuy Rating on Cardiol Therapeutics: Projected Blockbuster CardiolRx’s Strategic Advantages and Market PotentialApril 20, 2024 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc Purchase WT up on Tuesday (CRDL-WT-A)April 13, 2024 | seekingalpha.comCRDL:CA Cardiol Therapeutics Inc.February 21, 2024 | finance.yahoo.comCardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent PericarditisFebruary 9, 2024 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc Purchase WT down on Monday (CRDL-WT-A)February 2, 2024 | finance.yahoo.comIs Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?January 30, 2024 | morningstar.comCardiol Therapeutics Inc Class ADecember 5, 2023 | finance.yahoo.comCardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-PilotNovember 1, 2023 | proactiveinvestors.comCardiol Therapeutics reaches new milestone in Phase II study for recurrent pericarditisNovember 1, 2023 | finance.yahoo.comCardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study in Recurrent PericarditisOctober 23, 2023 | finanznachrichten.deCardiol Therapeutics Inc.: Cardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementOctober 13, 2023 | finance.yahoo.comCardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart DiseasesOctober 13, 2023 | finance.yahoo.comCardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart DiseasesOctober 11, 2023 | proactiveinvestors.comCardiol Therapeutics releases positive study results of...Cardiol Therapeutics releases positive study results of...October 10, 2023 | benzinga.comCBD To Treat Heart Failure? New Study Shows Its Cardioprotective EffectsSeptember 28, 2023 | finanznachrichten.deCardiol Therapeutics Inc.: Cardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare ConferenceSeptember 26, 2023 | finance.yahoo.comCardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare ConferenceSeptember 19, 2023 | proactiveinvestors.comCardiol Therapeutics on track to complete enrollment for acute myocarditis trial six months ahead of scheduleAugust 16, 2023 | msn.comCardiol Therapeutics Inc. (CRDL) Upgraded to Buy: Here's What You Should KnowJune 6, 2023 | finance.yahoo.comCRDL.TO - Cardiol Therapeutics Inc.May 19, 2023 | investing.comCardiol Therapeutics (CRDL) Earnings Dates & ReportsMay 9, 2023 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc down on Monday (CRDL)April 21, 2023 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc up on Friday (CRDL)April 12, 2023 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc up on Tuesday (CRDL)April 8, 2023 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc flat on Thursday (CRDL)April 6, 2023 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc down on Wednesday (CRDL)April 1, 2023 | uk.finance.yahoo.comCardiol Therapeutics Inc. (CRDL.TO)March 7, 2023 | finance.yahoo.comCardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating Cardioprotective Effects of Cannabidiol in a Model of Heart FailureFebruary 17, 2023 | seekingalpha.comCRDL Cardiol Therapeutics Inc.January 17, 2023 | proactiveinvestors.comCardiol Therapeutics enrols first patient in Phase 2 study of CardiolRx for Recurrent PericarditisDecember 12, 2022 | finanznachrichten.deCardiol Therapeutics Inc.: Cardiol Therapeutics Commences Multi-Center Phase II Pilot Study of CardiolRx for the Treatment of Recurrent PericarditisDecember 12, 2022 | finance.yahoo.comCardiol Therapeutics Commences Multi-Center Phase II Pilot Study of CardiolRx(TM) for the Treatment of Recurrent PericarditisNovember 15, 2022 | finance.yahoo.comCardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementNovember 7, 2022 | finance.yahoo.comCardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx(TM) in a Model of Acute PericarditisOctober 25, 2022 | proactiveinvestors.comCardiol Therapeutics to prioritize its Phase II clinical programs focused on developing CardiolRx for two underserved diseases affecting the heartOctober 25, 2022 | finance.yahoo.comCardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart DiseasesOctober 3, 2022 | proactiveinvestors.comCardiol Therapeutics unveils new preclinical study results providing evidence of cardioprotective properties of CardiolRxOctober 3, 2022 | finance.yahoo.comCardiol Therapeutics Announces Pre-Clinical Study Results Demonstrating CardiolRx(TM) Inhibits and also Promotes Reversal of Mechanisms Leading to Cardiac FibrosisSeptember 28, 2022 | finance.yahoo.comCardiol Therapeutics Announces Poster Presentation at The Annual Scientific Meeting of the Heart Failure Society of AmericaAugust 3, 2022 | proactiveinvestors.comCardiol Therapeutics says first patient enrolled in acute myocarditis trial of its oral cannabinoid formulation CardiolRxAugust 3, 2022 | proactiveinvestors.comCardiol Therapeutics hits major milestone with first patient enrolled in Phase 2 trial of CardiolRXJuly 18, 2022 | finanznachrichten.deFinancialnewsmedia.com: Air Pollution is a Global Heart and Lung Health Concern Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Nvidia insiders dumping shares (Ad)All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can. To see Porter Stansberry's new AI prediction go here now. CRDL Media Mentions By Week CRDL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRDL News Sentiment▼0.000.62▲Average Medical News Sentiment CRDL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRDL Articles This Week▼10▲CRDL Articles Average Week Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Canopy Growth News Knight Therapeutics News Aurora Cannabis News Organigram News Cipher Pharmaceuticals News BioSyent News HLS Therapeutics News Charlotte's Web News MediPharm Labs News Decibel Cannabis News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:CRDL) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
